TELA Bio, Inc. (TELA) Form 8-K Material Events
TELA Bio, Inc. (TELA) is a publicly traded company on the Nasdaq, categorized under SIC 3841 (Surgical & Medical Instruments & Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TELA
CIK: 1561921
Exchange: Nasdaq
SIC 3841: Surgical & Medical Instruments & Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerRyan McCullough
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-08 | 2026-10-08 | FORM 8-K | 0001104659-26-114695 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-10-05 | FORM 8-K | 0001104659-26-114042 | View SEC Doc Filr Page |
| 8-K | 2026-10-05 | 2026-10-05 | FORM 8-K | 0001104659-26-113506 | View SEC Doc Filr Page |
| 8-K | 2026-09-29 | 2026-09-28 | FORM 8-K | 0001104659-26-111920 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | 4 Filing | 0001456817-26-000015 | View SEC Doc Filr Page |
| 8-K | 2026-09-18 | 2026-09-15 | FORM 8-K | 0001104659-26-108935 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | 4 Filing | 0001456817-26-000013 | View SEC Doc Filr Page |
| DEF 14A | 2026-09-14 | 2026-10-08 | DEF 14A | 0001104659-26-107491 | View SEC Doc Filr Page |
| PRE 14A | 2026-09-04 | 2026-10-08 | PRE 14A | 0001104659-26-105492 | View SEC Doc Filr Page |
| 8-K | 2026-08-31 | 2026-08-28 | FORM 8-K | 0001104659-26-103548 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 Filing | 0001481485-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-14 | 4 Filing | 0001481485-26-000006 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097280 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-096813 | View SEC Doc Filr Page |
| 8-K/A | 2026-08-13 | 2026-08-03 | FORM 8-K/A | 0001104659-26-095892 | View SEC Doc Filr Page |
| S-8 | 2026-08-11 | — | S-8 | 0001104659-26-094126 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001104659-26-094039 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-11 | — | SCHEDULE 13G Filing | 0001104659-26-093857 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | FORM 8-K | 0001104659-26-093371 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | 4 Filing | 0001481485-26-000004 | View SEC Doc Filr Page |
| 3 | 2026-08-05 | 2026-08-03 | 3 Filing | 0001481485-26-000003 | View SEC Doc Filr Page |
| S-8 | 2026-08-04 | — | FORM S-8 | 0001104659-26-090468 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-03 | FORM 8-K | 0001104659-26-090056 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-15 | 4 Filing | 0001685640-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-15 | 4 Filing | 0001456817-26-000011 | View SEC Doc Filr Page |